CBLLCeriBell, Inc.
$23.15+96% 1Y
$23.15
$10.9252 weeks$25.01
The financials
CeriBell, Inc. by the numbers
CeriBell, Inc. (CBLL) reported revenue of $28M in Q2 2026 (quarter ended Jun 30, 2026), up 33% from the same quarter a year earlier. That came with a gross margin of 92% and net loss of $19M. For the full year FY2025, revenue was $89M (+36% year on year) and net income −$53M. The next results filing is expected around Nov 3, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $28M | $21M | +33% |
| Gross profit | $26M | $19M | +39% |
| Operating income | −$20M | −$15M | n/a |
| Net income | −$19M | −$14M | n/a |
| Diluted EPS | −$0.51 | −$0.38 | n/a |
Medical Devices
The closest names by size in the same industry